Nevro Company Overview
About Nevro
Nevro (NYSE:NVRO) is a company that designs, develops, and commercializes innovative medical devices for the management of chronic pain. It is primarily known for its flagship product, the Senza system, which utilizes high-frequency spinal cord stimulation technology to deliver relief without the paresthesia commonly associated with traditional systems. Nevro is committed to enhancing the quality of life for its patients by providing advanced solutions that address complex pain challenges. Their ongoing projects include expanding the application of their technology to cover a broader range of chronic pain conditions and continuously improving the effectiveness and user experience of their products. The objective of Nevro is to become a global leader in the pain management sector by delivering high-quality, innovative pain relief solutions to patients worldwide.
Snapshot
Operations
Produtos e/ou serviços de Nevro
- Senza SCS system offering high-frequency (10 kHz) therapy for chronic pain relief.
- Omnia SCS platform, a comprehensive solution for the management of chronic pain.
- Senza Omnia system, enabling a wide range of frequencies for pain management.
- HF10 therapy, a non-opioid treatment option for back and leg pain.
- Omnia 3D algorithm, optimizing spinal cord stimulation settings for individual patient needs.
- Remote patient monitoring services, enhancing patient care and outcomes.
equipe executiva do Nevro
- Mr. Kevin R. ThornalPresident, CEO & Director
- Mr. Roderick H. MacLeodSenior VP & CFO
- Mr. Kashif Rashid J.D.Senior VP of Corporate Development & Chief Legal Officer
- Mr. Greg SillerSenior VP & Chief Commercial Officer
- Mr. Christofer ChristoforouSenior VP & COO
- Ms. Angeline C. McCabeVice President of Investor Relations & Corporate Communications
- Ms. Shana D. Ross M.B.A.Senior VP & Chief Human Resources Officer
- Dr. David Caraway M.D., Ph.D.Senior VP & Chief Medical Officer
- Mr. Peter A. SocarrasVP, General Counsel & Corporate Secretary